This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Hexatrione 2%

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230110

Version

3

Spl Product Data Elements

Hexatrione 2% triamcinolone hexacetonide SODIUM HYDROXIDE SORBITOL SOLUTION 70% WATER HYDROCHLORIC ACID BENZYL ALCOHOL POLYSORBATE 80 TRIAMCINOLONE HEXACETONIDE TRIAMCINOLONE ACETONIDE

Brand Name

Hexatrione 2%

Generic Name

triamcinolone hexacetonide

Product Ndc

59137-570

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRA-ARTICULAR

Package Label Principal Display Panel

20 mg/mL (2 mL Ampoule) - Ampoule Label 20 mg/mL (2 mL Ampoule) - Carton Label Ampoule Label Carton

How Supplied

NDC 59137-570-01 2 mL single-dose ampoule (40 mg/2mL). One ampoule per carton.

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.